NCT00862355

Who might be able to join this trial:

• You must be available for the full length of the study and willing to follow all study requirements.
• You must have an official diagnosis of ovarian cancer and be suitable to receive a specific dose of a drug called liposomal doxorubicin.
• You must be 18 years of age or older.
• You must have no significant other health conditions found during screening, with a physical check-up completed within 21 days before the study begins.
• You must score 2 or lower on a standard scale that measures how much your illness affects your daily activities (confirm with trial site).
• Your blood test results at screening must be within normal ranges, or considered not medically significant by the study doctor.
• You must be willing and able to sign a written consent form agreeing to take part.

Who may not be able to join:

• You have had a significant allergic or unusual reaction to doxorubicin or similar medicines in the past.
• You have a significant history of heart, lung, liver, kidney, stomach, hormone, immune system, skin, muscle, nerve, or mental health conditions.
• You have had a problem with alcohol or drug misuse or addiction in the past year.
• You have had a significant illness (other than ovarian cancer) in the 4 weeks before the study starts.
• You have tested positive for HIV, hepatitis C, hepatitis B, or syphilis.
• You have taken certain medicines that affect how the body processes drugs (such as Phenytoin, Carbamazepine, or Barbiturates) in the 30 days before or during the study.
• You have donated 350 mL or more of blood in the 90 days before the study starts.
• You have taken part in another clinical trial in the 90 days before this study starts.
• Your blood pressure or pulse rate falls outside the acceptable ranges set by the study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.